首页> 美国卫生研究院文献>Proceedings of the National Academy of Sciences of the United States of America >From the Cover: Diversity-oriented combinatorial biosynthesis of benzenediol lactone scaffolds by subunit shuffling of fungal polyketide synthases
【2h】

From the Cover: Diversity-oriented combinatorial biosynthesis of benzenediol lactone scaffolds by subunit shuffling of fungal polyketide synthases

机译:从封面开始:通过真菌聚酮化合物合酶的亚基改组以多样性为导向的苯二醇内酯支架的组合生物合成

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Combinatorial biosynthesis aspires to exploit the promiscuity of microbial anabolic pathways to engineer the synthesis of new chemical entities. Fungal benzenediol lactone (BDL) polyketides are important pharmacophores with wide-ranging bioactivities, including heat shock response and immune system modulatory effects. Their biosynthesis on a pair of sequentially acting iterative polyketide synthases (iPKSs) offers a test case for the modularization of secondary metabolic pathways into “build–couple–pair” combinatorial synthetic schemes. Expression of random pairs of iPKS subunits from four BDL model systems in a yeast heterologous host created a diverse library of BDL congeners, including a polyketide with an unnatural skeleton and heat shock response-inducing activity. Pairwise heterocombinations of the iPKS subunits also helped to illuminate the innate, idiosyncratic programming of these enzymes. Even in combinatorial contexts, these biosynthetic programs remained largely unchanged, so that the iPKSs built their cognate biosynthons, coupled these building blocks into chimeric polyketide intermediates, and catalyzed intramolecular pairing to release macrocycles or α-pyrones. However, some heterocombinations also provoked stuttering, i.e., the relaxation of iPKSs chain length control to assemble larger homologous products. The success of such a plug and play approach to biosynthesize novel chemical diversity bodes well for bioprospecting unnatural polyketides for drug discovery.
机译:组合生物合成渴望利用微生物合成代谢途径的混杂来工程化新化学实体的合成。真菌苯二醇内酯(BDL)聚酮化合物是重要的药效团,具有广泛的生物活性,包括热休克反应和免疫系统调节作用。他们在一对顺序作用的迭代聚酮化合物合酶(iPKS)上的生物合成为将次级代谢途径模块化成“构建-偶联-配对”组合合成方案提供了一个测试案例。来自四个BDL模型系统的iPKS亚基随机对在酵母异源宿主中的表达创建了一个多样化的BDL同族文库,包括具有非天然骨架和诱导热休克反应活性的聚酮化合物。 iPKS亚基的成对异源组合也有助于阐明这些酶的先天性,异质性编程。即使在组合的情况下,这些生物合成程序也基本上保持不变,因此iPKS可以构建其同源生物合成子,将这些结构单元偶联到嵌合聚酮化合物中间体中,并催化分子内配对以释放大环或α-吡喃酮。然而,一些杂合也引起了口吃,即,放松了iPKSs链长控制以组装更大的同源产物。这种即插即用的生物合成新化学多样性方法的成功预示着生物勘探非天然聚酮化合物用于药物发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号